Comparison of 1-Year Outcomes of Triple (Aspirin + Clopidogrel + Cilostazol) Versus Dual Antiplatelet Therapy (Aspirin + Clopidogrel + Placebo) After Implantation of Second-Generation Drug-Eluting Stents into One or More Coronary Arteries: from the DECREASE-PCI Trial

MLA

Jae-Hwan Lee, et al. “Comparison of 1-Year Outcomes of Triple (Aspirin + Clopidogrel + Cilostazol) Versus Dual Antiplatelet Therapy (Aspirin + Clopidogrel + Placebo) After Implantation of Second-Generation Drug-Eluting Stents into One or More Coronary Arteries: From the DECREASE-PCI Trial.” The American Journal of Cardiology, vol. 121, Feb. 2018, pp. 423–29. EBSCOhost, https://doi.org/10.1016/j.amjcard.2017.11.005.

APA

Jae-Hwan Lee, Duk-Woo Park, Jae Bin Seo, Si Wan Choi, Cheol Whan Lee, Seong Wook Park, Pil-Ki Min, Cheol Hyun Lee, Seung-Whan Lee, Pil Hyung Lee, Jung-Min Ahn, Sung Ho Her, Youngjin Choi, Gyung Min Park, Jang Hyun Cho, Seung-Jung Park, Soo Jin Kang, Young-Hak Kim, Chang-Wook Nam, … Hyun-Sook Kim. (2018). Comparison of 1-Year Outcomes of Triple (Aspirin + Clopidogrel + Cilostazol) Versus Dual Antiplatelet Therapy (Aspirin + Clopidogrel + Placebo) After Implantation of Second-Generation Drug-Eluting Stents into One or More Coronary Arteries: from the DECREASE-PCI Trial. The American Journal of Cardiology, 121, 423–429. https://doi.org/10.1016/j.amjcard.2017.11.005

Chicago

Jae-Hwan Lee, Duk-Woo Park, Jae Bin Seo, Si Wan Choi, Cheol Whan Lee, Seong Wook Park, Pil-Ki Min, et al. 2018. “Comparison of 1-Year Outcomes of Triple (Aspirin + Clopidogrel + Cilostazol) Versus Dual Antiplatelet Therapy (Aspirin + Clopidogrel + Placebo) After Implantation of Second-Generation Drug-Eluting Stents into One or More Coronary Arteries: From the DECREASE-PCI Trial.” The American Journal of Cardiology 121 (February): 423–29. doi:10.1016/j.amjcard.2017.11.005.